Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib

Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib

Abstract Background Nilotinib, a second-generation BCR-ABL tyrosine kinase inhibitor (TKI), is highly effective in the treatment of patients with chronic myeloid leukemia (CML), despite being more vasculotoxic than older TKIs such as imatinib. Herein, we present a case of nilotinib-associated vasosp...

Full description

Bibliographic Details
Main Authors: Shunsuke Maruta, Kyohei Usami, Kazuko Tajiri, Masafumi Otani, Daigo Hiraya, Hiroaki Watabe, Tomoya Hoshi, Akira Sato, Masaki Ieda
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Cardio-Oncology
Subjects:
Chronic myeloid leukemia
Coronary angiography
Coronary circulation
Coronary spasm
Vasospastic angina
Tyrosine kinase inhibitor
Online Access:https://doi.org/10.1186/s40959-021-00119-6

Internet

https://doi.org/10.1186/s40959-021-00119-6

Similar Items